This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Valueact Buys $31.5M Worth of Valeant

Stocks in this article: VPHM VRX

Which insiders are selling and buying chunks of stocks?

Below are lists of the top 10 open-market insider purchases and sales filed at the Securities and Exchange Commission Monday as ranked by dollar value. Company executives and directors are in the best position to assess the attractiveness of their firms' shares, and here is how many of them are voting their wallets!

Insider Insights

Dollar value is only one metric to assess the importance of an insider transaction, however. For more value-added tables on a weekly basis, and fundamentally researched investment ideas inspired by insiders, subscribe to's InsiderInsights newsletter. Whether you're a growth, value, income, momentum, or microcap investor, insider data can help you find great investment ideas.

Also check out Stockpickr's weekly "Top Stocks With Insider Buying, Buybacks."

Company Name (Ticker) Filer Name
Valeant Pharmaceuticals (VRX) Valueact Holdings LP BO 1,637,514 $31,522,287
Genomic Health (GHDX) Baker Brothers Life Sciences Capital LLC DIR,BO 137,466 $2,686,788
Viropharma (VPHM) Baker Brothers Life Sciences Capital LLC BO 446,857 $2,596,730
Walter Investment Mgt (WAC) Tokarz Michael T DIR 68,700 $736,117
Biospecifics Technologies (BSTC) Ra Capital Management LLC BO 15,759 $306,538
Superconductor Technologies (SCON) Kopp Leroy C BO 79,000 $260,979
Heritage Bankshares (HBKS) Kaufman David L DIR 20,000 $200,000
Lifetime Brands (LCUT) Siegel Jeffrey CB,CEO,
50,000 $131,000
Inergy LP (NRGY) Sherman John J CEO,PR,
5,000 $112,500
Rae Systems (RAE) Kopp Leroy C BO 57,500 $67,250
Company Name (Ticker) Filer Name
Microsoft (MSFT) Gates William H III DIR 1,000,000 $19,548,200
Hunt J B Transport Services (JBHT) Garrison Earl Wayne CB,DIR 365,454 $10,429,929
XTO Energy (XTO) Simpson Bob R CB,DIR 196,311 $8,730,696
XTO Energy (XTO) Simpson Gary D VP,FO,
50,000 $2,186,500
Fastenal (FAST) Kierlin Robert A DIR 50,000 $1,825,950
Boston Scientific (BSX) Abele John E DIR 200,000 $1,807,900
XTO Energy (XTO) Vennerberg Vaughn O II PR,DIR 25,000 $1,078,600
Infogroup (IUSA) Gupta Vinod DIR,BO 194,176 $1,010,589
IntercontinentalExchange (ICE) Salerno Frederic V DIR 10,283 $1,002,951
Gamco Investors (GBL) Alpert Bruce N VP 17,500 $902,522
Key to Titles: A=Assistant, AI=Affiliated Investor, AO=Accounting Officer, BD=Business Development, BO=Beneficial Owner, CAO=Chief Accounting Officer, CB=Chairman, CCO=Chief Compliance Officer, CEO=Chief Executive Officer, CFO=Chief Financial Officer, CIO=Chief Information Officer, CO=Compliance Officer, COO=Chief Operating Officer, CT=Controller, CTO=Chief Technology Officer, DIR=Director, F=Founder, FO=Financial Officer, GC=General Counsel, HR=Human Resources, IO=Information Officer, IR=Investor Relations, LO=Legal Officer, MD=Managing Director, O=Officer, OO=Operating Officer, PR=President, PT=Partner, REL=Relative of an insider, SEC=Secretary, SH=Shareholder, SO=Sales Officer, TO=Technology Officer, TR=Treasurer, TT=Trustee, VCB=Vice Chairman, VP=Vice President, X=Ex Officer or other title displayed.

Jonathan Moreland is director of research and publisher of the weekly publication InsiderInsights, founder of the Web site and the director of research at Insider Asset Management LLC. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. While he cannot provide investment advice or recommendations, Moreland appreciates your feedback; click here to send him an email.

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,164.95 -251.90 -1.45%
S&P 500 1,994.99 -26.26 -1.30%
NASDAQ 4,635.24 -48.1670 -1.03%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs